BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Leukemia
,
Embryo
,
Hematopoietic cell
,
Fluoxetine
,
rs6983267
,
PPARA
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
fms like tyrosine kinase
Summary
General Info
Curated Studies
Most Correlated Studies
L1000 CMAP - Amelanotic malignant melanoma of skin A375 cells treated with ligand perturbagens
L1000 CMAP - Embryonic kidney epithelial HA1E cells treated with ligand perturbagens
L1000 CMAP - Non-small cell lung cancer HCC515 cells treated with ligand perturbagens
L1000 CMAP - Prostate carcinoma VCaP cells treated with ligand perturbagens
L1000 CMAP - Adenocarcinoma of breast MCF7 cells treated with ligand perturbagens
Explore Curated Studies Results
Literature
Most Relevant Literature
Conjugation of VEGFR1/R2-targeting peptide with gold nanoparticles to enhance antiangiogenic and ant…
Role of the NF-kB/parkin/vegfr-1 pathway associated with hypoxic-ischemic insult in germinal matrix …
VEGF-A/VEGFR-1 signalling and chemotherapy-induced neuropathic pain: therapeutic potential of a nove…
Structure-activity relationships of natural quinone vegfrecine analogs with potent activity against …
An Investigation of Vascular Endothelial Growth Factor (VEGFR-1 and VEGFR-2) in Burn Wound Healing.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
A Study of ASP2215 (Gilteritinib) Combined With Atezolizumab in Patients With Relapsed or Treatment …
Early Access Program (EAP) of Gilteritinib (ASP2215) in Patients With FMS-like Tyrosine Kinase 3 (FL…
A Study of ASP2215 (Gilteritinib), Administered as Maintenance Therapy Following Induction/Consolida…
A Study to Assess the Safety of Xospata in Patients With Relapsed or Refractory Acute Myeloid Leukem…
A Study of ASP2215 Versus Salvage Chemotherapy in Patients With Relapsed or Refractory Acute Myeloid…
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ